Yechiel Shai

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 4

Top Topics

Inflammatory Response

Staphylococcus Aureus

Top Venues

ACS pharmacology & translational science

This page only lists publications with an associated author ORCID identifier.

Publications

Avner Fink, Daniel Ben Hur, Naiem Ahmad Wani, Hadar Cohen, Li-Av Segev-Zarko, Christopher J Arnusch, Yechiel Shai
Development of Nontoxic Peptides for Lipopolysaccharide Neutralization and Sepsis Treatment. ACS pharmacology & translational science 7 (6) (2024)
Avner Fink, Daniel Ben Hur, Naiem Ahmad Wani, Hadar Cohen, Li-Av Segev-Zarko, Christopher J Arnusch, Yechiel Shai
Development of Nontoxic Peptides for Lipopolysaccharide Neutralization and Sepsis Treatment. ACS pharmacology & translational science 7 (6) (2024)
Hadar Cohen, Naiem Ahmad Wani, Daniel Ben Hur, Ludovico Migliolo, Marlon Henrique Cardoso, Ziv Porat, Eyal Shimoni, Octávio Luiz Franco, Yechiel Shai
Interaction of Pexiganan (MSI-78)-Derived Analogues Reduces Inflammation and TLR4-Mediated Cytokine Secretion: A Comparative Study. ACS omega 8 (20) (2023)
Etai Rotem, Omri Faingold, Meital Charni, Yoel A Klug, Daniel Harari, Liraz Shmuel-Galia, Alon Nudelman, Varda Rotter, Yechiel Shai
The HTLV-1 gp21 fusion peptide inhibits antigen specific T-cell activation in-vitro and in mice. PLoS pathogens 14 (5) (2018)